The French pharmaceutical giant Sanofi has agreed to pay digital health company Dario Health $30 million to market its diabetes products. In return, Dario Health will have access to Sanofi’s sales team to market its smartphone-connected glucometer and app to help people manage their diabetes, as well as its other new technology including devices to help people correct their posture, monitor physical training exercises at home, and provide on line treatments for depression. The plan is to create a one-stop shop for solutions for chronic conditions and sell the technology into company health plans, but deals are not expected to be signed until later in 2023. “Our collaboration with Dario is another step towards accelerating Sanofi’s mission of reversing the course of chronic diseases through the integration of healthcare and technology in a way that gives people the tools to improve their health,” said Sanofi’s head of general medicine in America, Gustavo Pesquin. “We are excited to help payers realize the potential that digital health can bring to the patient experience, and we look forward to continuing to innovate with Dario on the next generation of chronic condition therapies.” For more information CLICK HERE
